Motoyuki Tamaki Selected Research

Therapeutics

10/2018	Up-Titration Strategy After DPP-4 Inhibitor-Based Oral Therapy for Type 2 Diabetes: A Randomized Controlled Trial Shifting to a Single-Dose GLP-1 Enhancer Versus Adding a Variable Basal Insulin Algorithm.
11/2013	Beneficial effects of vildagliptin combined with miglitol on glucose tolerance and islet morphology in diet-controlled db/db mice.
1/2011	Efficacy of pioglitazone on glycemic control and carotid intima-media thickness in type 2 diabetes patients with inadequate insulin therapy.
8/2008	Effects of changes in basal/total daily insulin ratio in type 2 diabetes patients on intensive insulin therapy including insulin glargine (JUN-LAN Study 6).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Motoyuki Tamaki Research Topics

Disease

9	Type 2 Diabetes Mellitus (MODY) 01/2024 - 08/2008
3	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 07/2022 - 03/2017
2	Diabetic Angiopathies (Diabetic Angiopathy) 09/2019 - 01/2015
2	Atherosclerosis 01/2015 - 01/2011
2	Insulin Resistance 01/2014 - 06/2011
1	Albuminuria 10/2023
1	Diabetic Nephropathies (Diabetic Nephropathy) 10/2023
1	Inflammation (Inflammations) 10/2023
1	Proteinuria 10/2023
1	Sarcopenia 09/2019
1	Body Weight (Weight, Body) 10/2018
1	Muscle Weakness 05/2017
1	Carotid Artery Diseases 01/2015
1	Amyloid Plaque 08/2014
1	Critical Illness (Critically Ill) 09/2008

Drug/Important Bio-Agent (IBA)

8	Insulin (Novolin)FDA Link 07/2022 - 08/2008
3	Advanced Glycation End ProductsIBA 09/2019 - 01/2015
2	Glucose (Dextrose)FDA LinkGeneric 10/2023 - 03/2017
2	Biomarkers (Surrogate Marker)IBA 10/2023 - 01/2015
2	Dipeptidyl-Peptidase IV InhibitorsIBA 10/2018 - 11/2013
2	Glucagon-Like Peptide 1 (GLP 1)IBA 10/2018 - 11/2013
2	Insulin Glargine (Lantus)FDA Link 03/2017 - 08/2008
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 10/2023
1	Sodium-Glucose Transporter 2 InhibitorsIBA 10/2023
1	AngiotensinsIBA 10/2023
1	ReninIBA 10/2023
1	SodiumIBA 10/2023
1	DNA (Deoxyribonucleic Acid)IBA 07/2022
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 10/2018
1	Liraglutide FDA Link 10/2018
1	insulin degludecIBA 03/2017
1	Islet Amyloid PolypeptideIBA 08/2014
1	ZincIBA 01/2014
1	Glycoside Hydrolase InhibitorsIBA 11/2013
1	Pioglitazone (Actos)FDA Link 01/2011

Therapy/Procedure

4	Glycemic Control 01/2024 - 08/2008
4	Therapeutics 10/2018 - 08/2008
1	Aftercare (After-Treatment) 10/2023
1	Injections 03/2017